ADC 有效载荷是诱导抗体药物偶联物 (ADC) 中的靶细胞死亡的细胞毒性剂。ADC 是一种由单克隆抗体、连接子和有效载荷组成的靶向药物。有效载荷是最重要的成分,因为它决定了 ADC 杀死癌细胞的效力。
目前正在使用的有效载荷有很多,例如卡利车霉素、多卡米星、吡咯并苯二氮卓 (PBD)、喜树碱、柔红霉素/阿霉素、奥瑞他汀和美登木素。根据作用机制,它们可分为两类:DNA 损伤剂和微管蛋白抑制剂。其中卡利车霉素、多卡米星和PBDs是DNA小沟结合剂,喜树碱和柔红霉素/阿霉素是拓扑异构酶抑制剂,具有DNA损伤作用,奥瑞他汀和美登素是微管蛋白抑制剂。
ADC payloads are cytotoxic agents that induce target cell death in Antibody Drug Conjugates (ADCs). An ADC is a targeted agent composed with a monoclonal antibody, a linker and a payload. The payload is the most important component as it determines the potency to kill cancer cells of an ADC.
There are many payloads which are currently being used such as Calicheamicins, Duocarmycins, Pyrrolobenzodiazepines (PBDs), Camptothecins, Daunorubicins/Doxorubicins, Auristatins and Maytansinoids. They can be divided in two classes based on their mechanism of action, DNA damaging agents and tubulin inhibitors. Among them Calicheamicins, Duocarmycins and PBDs are DNA minor grove binders, Camptothecins and Daunorubicins/Doxorubicins are topoisomerase inhibitors, which are DNA damaging agents. Auristatins and Maytansinoids are tubulin inhibitors.
Exatecan intermediate 12 是合成 ADC 毒素 Exatecan (MS-Z28405) 的中间体,可用于制备 ADC 类化合物。
Monomethyl auristatin E intermediate-14 是合成 Monomethyl auristatin E (MS-Q21073) 的中间反应物,而 Monomethyl auristatin E (MMAE) 是一种具有抗癌活性的微管蛋白聚合 (Microtubule/Tubulin) 抑制剂,被广泛用作抗体-药物偶联物 (ADCs) 的细胞毒性成分 (ADC Cytotoxin)。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号